These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8032284)

  • 41. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
    Mahon BP; Katrak K; Nomoto A; Macadam AJ; Minor PD; Mills KH
    J Exp Med; 1995 Apr; 181(4):1285-92. PubMed ID: 7699320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis.
    Gromeier M; Lu HH; Wimmer E
    Microb Pathog; 1995 Apr; 18(4):253-67. PubMed ID: 7476091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I; Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple host barriers restrict poliovirus trafficking in mice.
    Kuss SK; Etheredge CA; Pfeiffer JK
    PLoS Pathog; 2008 Jun; 4(6):e1000082. PubMed ID: 18535656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon.
    Arita M; Nagata N; Sata T; Miyamura T; Shimizu H
    J Gen Virol; 2006 Nov; 87(Pt 11):3317-3327. PubMed ID: 17030866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Provocation poliomyelitis and entry of poliovirus to the CNS.
    Wyatt HV
    Med Hypotheses; 1976; 2(6):269-74. PubMed ID: 187911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10.
    Jackson CA; Messinger J; Peduzzi JD; Ansardi DC; Morrow CD
    Virology; 2005 Jun; 336(2):173-83. PubMed ID: 15892959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of dissemination pathways for poliovirus].
    Ohka S
    Uirusu; 2009 Jun; 59(1):107-14. PubMed ID: 19927995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular mechanism of tissue-specific infection of poliovirus].
    Koike S
    Uirusu; 2004 Dec; 54(2):205-12. PubMed ID: 15745158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poliovirus induces apoptosis in the mouse central nervous system.
    Girard S; Couderc T; Destombes J; Thiesson D; Delpeyroux F; Blondel B
    J Virol; 1999 Jul; 73(7):6066-72. PubMed ID: 10364359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of brain-derived neurotrophic factor in the central nervous system of mice using a poliovirus-based vector.
    Jia Q; Liang F; Ohka S; Nomoto A; Hashikawa T
    J Neurovirol; 2002 Feb; 8(1):14-23. PubMed ID: 11847588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Practical development of genetically engineered animals as human disease models.
    Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):113-7. PubMed ID: 9150486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus. A meeting report of the WHO Global Programme for Vaccines and Immunization and the WHO Biologicals Unit, Geneva, Switzerland, 26-28 September 1996.
    Vaccine; 1997 Mar; 15(4):341-5. PubMed ID: 9141201
    [No Abstract]   [Full Text] [Related]  

  • 54. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.
    Dragunsky E; Gardner D; Taffs R; Levenbook I
    Biologicals; 1993 Sep; 21(3):233-7. PubMed ID: 8117436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transgenic mice susceptible to poliovirus.
    Koike S; Taya C; Kurata T; Abe S; Ise I; Yonekawa H; Nomoto A
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):951-5. PubMed ID: 1846972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excretion of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-transgenic mice.
    Boot HJ; Kasteel DT; Buisman AM; Kimman TG
    J Virol; 2003 Jun; 77(11):6541-5. PubMed ID: 12743311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Poliovirus infection in the transgenic mouse model].
    Koike S
    Jikken Dobutsu; 1993 Jul; 42(3):296-9. PubMed ID: 8394822
    [No Abstract]   [Full Text] [Related]  

  • 58. [Tissue tropism and species specificity of poliovirus infection].
    Aoki J
    Tanpakushitsu Kakusan Koso; 1994 Sep; 39(12):2081-9. PubMed ID: 7938605
    [No Abstract]   [Full Text] [Related]  

  • 59. Poliovirus and its cellular receptor: a molecular genetic dissection of a virus/receptor affinity interaction.
    Solecki D; Gromeier M; Harber J; Bernhardt G; Wimmer E
    J Mol Recognit; 1998; 11(1-6):2-9. PubMed ID: 10076797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity.
    Gromeier M; Lu HH; Bernhardt G; Harber JJ; Bibb JA; Wimmer E
    Ann N Y Acad Sci; 1995 May; 753():19-36. PubMed ID: 7611627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.